ubmslateRN-logo-ubm

RN Mobile Menu

Search form

Topics:

Michael Wyand PhD DVM

Michael Wyand PhD DVM

Dr. Wyand is Senior Vice President of Clinical, Regulatory and Manufacturing at Epirus Biopharmaceuticals, which is based in Boston.

Posts by Author

(ACR14) (VIDEO) In tests so far, the infliximab biosimilar BOW015, just approved in India, seems to look about the same to the human immune system as the original. Here, a VP of the company behind BOW015 talks about the realities of seeking approval in the US.

By clicking Accept, you agree to become a member of the UBM Medica Community.